Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9184 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8903 |
High Similarity |
NPD7075 |
Discontinued |
0.8836 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8836 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8831 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8831 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8824 |
High Similarity |
NPD7411 |
Suspended |
0.88 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8776 |
High Similarity |
NPD1549 |
Phase 2 |
0.8774 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8767 |
High Similarity |
NPD2796 |
Approved |
0.8766 |
High Similarity |
NPD6801 |
Discontinued |
0.8758 |
High Similarity |
NPD4380 |
Phase 2 |
0.871 |
High Similarity |
NPD7819 |
Suspended |
0.8699 |
High Similarity |
NPD1510 |
Phase 2 |
0.8684 |
High Similarity |
NPD920 |
Approved |
0.8591 |
High Similarity |
NPD1243 |
Approved |
0.8553 |
High Similarity |
NPD642 |
Clinical (unspecified phase) |
0.8553 |
High Similarity |
NPD2533 |
Approved |
0.8553 |
High Similarity |
NPD2534 |
Approved |
0.8553 |
High Similarity |
NPD2532 |
Approved |
0.8544 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8543 |
High Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8526 |
High Similarity |
NPD1934 |
Approved |
0.8487 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8481 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8467 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8467 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8457 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8428 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8425 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8418 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8415 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8411 |
Intermediate Similarity |
NPD3750 |
Approved |
0.84 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8366 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8354 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8354 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8323 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8311 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8288 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8288 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.828 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8272 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8267 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8267 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8263 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8258 |
Intermediate Similarity |
NPD1512 |
Approved |
0.825 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8214 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.8205 |
Intermediate Similarity |
NPD5403 |
Approved |
0.82 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8182 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8148 |
Intermediate Similarity |
NPD919 |
Approved |
0.8137 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8121 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.8121 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8121 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8121 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8121 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.811 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8095 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.8084 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8084 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.8084 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8079 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.8079 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8077 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8075 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8067 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8052 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8041 |
Intermediate Similarity |
NPD3268 |
Approved |
0.8036 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8036 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7988 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7987 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7945 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7945 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7941 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7935 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7905 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7895 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7892 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7892 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7888 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7857 |
Intermediate Similarity |
NPD2344 |
Approved |
0.78 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7793 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7784 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7753 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7753 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7742 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7742 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7742 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7742 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7742 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.774 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7736 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7725 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7709 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7709 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7707 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7703 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7703 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7674 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7667 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7667 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7658 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7651 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7647 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.764 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7635 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7576 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7564 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7564 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7551 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7551 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7546 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7546 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7532 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7528 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7517 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7515 |
Intermediate Similarity |
NPD37 |
Approved |
0.7515 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7514 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD1608 |
Approved |
0.75 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7485 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7485 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7469 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7468 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7455 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7455 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7453 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7453 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7451 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7451 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7451 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7451 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7444 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7443 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7443 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7427 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7427 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7425 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7421 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7421 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7419 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7419 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7417 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7414 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7397 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7375 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7355 |
Intermediate Similarity |
NPD943 |
Approved |
0.7342 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7342 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7342 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7342 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7338 |
Intermediate Similarity |
NPD411 |
Approved |
0.7333 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7302 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7297 |
Intermediate Similarity |
NPD17 |
Approved |
0.729 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7289 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7283 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD6808 |
Phase 2 |
0.7263 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7262 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7262 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7262 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.726 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7255 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7244 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7244 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7244 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7237 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7233 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7233 |
Intermediate Similarity |
NPD4477 |
Approved |
0.72 |
Intermediate Similarity |
NPD7228 |
Approved |
0.719 |
Intermediate Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.7184 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7173 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7169 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7162 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7161 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7152 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7152 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7135 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.7127 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.712 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7118
|
Intermediate Similarity |
NPD2296 |
Approved |